ATE362487T1 - N-substituierte l-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation - Google Patents

N-substituierte l-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation

Info

Publication number
ATE362487T1
ATE362487T1 AT00948175T AT00948175T ATE362487T1 AT E362487 T1 ATE362487 T1 AT E362487T1 AT 00948175 T AT00948175 T AT 00948175T AT 00948175 T AT00948175 T AT 00948175T AT E362487 T1 ATE362487 T1 AT E362487T1
Authority
AT
Austria
Prior art keywords
peptide
beta
substituted
nalpha
strand
Prior art date
Application number
AT00948175T
Other languages
English (en)
Inventor
Kelvin Stott
Original Assignee
Senexis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senexis Ltd filed Critical Senexis Ltd
Application granted granted Critical
Publication of ATE362487T1 publication Critical patent/ATE362487T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00948175T 1999-07-28 2000-07-28 N-substituierte l-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation ATE362487T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9917724.8A GB9917724D0 (en) 1999-07-28 1999-07-28 Peptides

Publications (1)

Publication Number Publication Date
ATE362487T1 true ATE362487T1 (de) 2007-06-15

Family

ID=10858096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00948175T ATE362487T1 (de) 1999-07-28 2000-07-28 N-substituierte l-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation

Country Status (10)

Country Link
US (1) US7125838B1 (de)
EP (1) EP1203019B1 (de)
JP (1) JP2003505469A (de)
AT (1) ATE362487T1 (de)
AU (1) AU766992B2 (de)
CA (1) CA2378779A1 (de)
DE (1) DE60034888D1 (de)
GB (1) GB9917724D0 (de)
NZ (1) NZ516441A (de)
WO (1) WO2001007473A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
AU2002320045B2 (en) 2001-05-31 2008-05-08 Adlyfe, Inc. Misfolded protein sensor method
DE10230141B4 (de) * 2002-07-04 2004-07-15 Priontype Gmbh Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
AU2003271745A1 (en) * 2002-07-08 2004-01-23 Laboratoires Serono Sa Beta-SHEET BREAKING PEPTIDES
CA2522460A1 (en) * 2003-04-30 2004-11-11 Applied Research Systems Ars Holding N.V. Beta-amyloid inhibitors and use thereof
EP1853915B1 (de) * 2005-02-15 2011-10-12 Adlyfe, Inc. Verfahren zum nachweis falsch gefalteter proteine und prionen
KR20090009189A (ko) * 2006-01-05 2009-01-22 유니버시티 오브 유타 리써치 파운데이션 신경계를 표적으로 하는 약제학적 제제의 특성 향상 방법및 특성 향상용 조성물
JP5097206B2 (ja) * 2006-07-28 2012-12-12 エイディーライフ インコーポレイティッド 診断および治療のためのペプチドプローブ
WO2011156003A2 (en) 2010-06-09 2011-12-15 New York University Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same
WO2012082942A2 (en) 2010-12-15 2012-06-21 Neuroadjuvants, Inc. Neuropeptide analogs, compositions, and methods for treating pain
WO2013054110A2 (en) * 2011-10-10 2013-04-18 University Of Lancaster Compositions for binding to amyloid proteins
US20240285688A1 (en) * 2019-11-07 2024-08-29 N.V. Nutricia Extensive whey protein hydrolysate with tolerogenic peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2214247C (en) * 1995-03-14 2004-02-10 Praecis Pharmaceuticals Incorporated Modulators of amyloid aggregation
EP0866805A1 (de) 1995-12-12 1998-09-30 Karolinska Innovations AB Peptide, das die KLVFF Sequenz von beta-Amyloid bindet
US6034211A (en) * 1996-06-03 2000-03-07 Kelly; Jeffery W. β-sheet nucleating peptidomimetics
DE19725619A1 (de) 1997-06-17 1998-12-24 Fraunhofer Ges Forschung Peptide als Agonisten und/oder Inhibitoren der Amyloidbildung und Zytotoxizität sowie der Verwendung bei Alzheimer'schen Krankheit, beim Typ II Diabetes mellitus und bei spongiformen Encephalopathien

Also Published As

Publication number Publication date
GB9917724D0 (en) 1999-09-29
EP1203019A1 (de) 2002-05-08
AU6173700A (en) 2001-02-13
NZ516441A (en) 2003-11-28
US7125838B1 (en) 2006-10-24
DE60034888D1 (de) 2007-06-28
CA2378779A1 (en) 2001-02-01
AU766992B2 (en) 2003-10-30
WO2001007473A1 (en) 2001-02-01
JP2003505469A (ja) 2003-02-12
EP1203019B1 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
SI1549333T1 (sl) Analogi kompstatina z izboljĺ ano aktivnostjo
NZ333609A (en) Peptide inhibitors of the interaction between P35 and MDM2 and the treatment of tumor cells
DE60034888D1 (de) N-substituierte l-aminosäuren enthaltende peptide, zur prävention der beta-strang assoziation
WO2000002917A3 (en) Compounds and methods for modulating cadherin-mediated functions
ATE423127T1 (de) Peptidinhibitoren der ns3-protease des hepatoitis c virus
SE0002202D0 (sv) New peptides
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
FI961044A0 (fi) Kininogeeni-inhibiittorit
ATE355302T1 (de) N-substituierte d-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation
DE60233558D1 (de) Aminosäurezusammensetzungen zur linderung einer fehlfunktion der leber
DK1079849T3 (da) Anvendelse af HMG-proteiner til fremstilling af lægemidler med cytotoksisk virkning
DK1387854T3 (da) SFRP og peptidmotiver som interagerer med SFRP og fremgangsmåder til anvendelse deraf
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
DE69812597D1 (de) Peptide zur Inhibition von HPV E7 Proteinen
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
AU2003288320A1 (en) Peptides binding the phosphatase 2a protein and polynucleotides encoding same
NZ591989A (en) Prion-specific peptide reagents
ATE492637T1 (de) An die lck-sh3 und hck-sh3 domäne bindende peptide
SE9804137D0 (sv) New peptides
WO2004011491A3 (en) Peptidyl-trna hydrolase of enterococcus faecalis
BRPI0216042B8 (pt) polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos.
ES1034253U (es) Grapa de fijacion perfeccionada, aplicable en hebillas, adornos y similares.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties